CVS Health Corporation (CVS)

CVS Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	360,935	357,776	322,467	292,111	268,706	256,776
Revenue Growth (YoY)	9.07%	10.95%	10.39%	8.71%	4.65%	31.96%
Cost of Revenue	307,318	303,345	267,965	239,991	219,660	211,248
Gross Profit	53,617	54,431	54,502	52,120	49,046	45,528
Selling, General & Admin	40,542	39,832	38,212	37,021	35,135	33,310
Other Operating Expenses	507	856	8,336	1,789	0	231
Operating Expenses	41,049	40,688	46,548	38,810	35,135	33,541
Operating Income	12,568	13,743	7,954	13,310	13,911	11,987
Interest Expense / Income	2,785	2,658	2,287	2,503	2,907	3,035
Other Expense / Income	-62	-64	-153	258	1,256	-48
Pretax Income	9,845	11,149	5,820	10,549	9,748	9,000
Income Tax	2,524	2,805	1,509	2,548	2,569	2,366
Net Income	7,321	8,344	4,311	8,001	7,179	6,634
Net Income Growth	78.87%	93.55%	-46.12%	11.45%	8.22%	-
Shares Outstanding (Basic)	1,260	1,285	1,312	1,319	1,309	1,301
Shares Outstanding (Diluted)	1,267	1,290	1,323	1,329	1,314	1,305
Shares Change	-1.86%	-2.49%	-0.45%	1.14%	0.69%	25.00%
EPS (Basic)	5.71	6.49	3.29	6.07	5.48	5.10
EPS (Diluted)	5.70	6.47	3.26	6.02	5.46	5.08
EPS Growth	82.69%	98.47%	-45.85%	10.26%	7.48%	-
Free Cash Flow	8,139	10,395	13,450	15,745	13,428	10,391
Free Cash Flow Per Share	6.46	8.09	10.25	11.94	10.26	7.99
Dividend Per Share	2.480	2.420	2.200	2.000	2.000	2.000
Dividend Growth	9.98%	10.00%	10.00%	0%	0%	0%
Gross Margin	14.86%	15.21%	16.90%	17.84%	18.25%	17.73%
Operating Margin	3.48%	3.84%	2.47%	4.56%	5.18%	4.67%
Profit Margin	2.03%	2.33%	1.34%	2.74%	2.67%	2.58%
Free Cash Flow Margin	2.25%	2.91%	4.17%	5.39%	5.00%	4.05%
Effective Tax Rate	25.64%	25.16%	25.93%	24.15%	26.35%	26.29%
EBITDA	12,630	13,807	8,107	13,052	17,096	16,406
EBITDA Margin	3.50%	3.86%	2.51%	4.47%	6.36%	6.39%
Depreciation & Amortization	0	0	0	0	4,441	4,371
EBIT	12,630	13,807	8,107	13,052	12,655	12,035
EBIT Margin	3.50%	3.86%	2.51%	4.47%	4.71%	4.69%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).